North Dakota State Investment Board
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 2064039
BISMARCK, ND
Position in ARWR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$324,409
New position
Shares Held
3,980
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#338
of 497 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026North Dakota State Investment Board holds $18,095,607 across 20 Biotechnology names. ARWR ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,547 | $3,748,821 | |
| 2 | MRNA |
Moderna, Inc.
|
43,152 | $3,021,934 | |
| 3 | INCY |
Incyte Corp
|
16,678 | $1,890,618 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,017 | $1,881,220 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,769 | $1,134,582 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
5,334 | $998,951 | |
| 7 | INSM |
INSMED Inc
|
6,226 | $663,816 | |
| 8 | RPRX |
Royalty Pharma plc
|
11,431 | $640,936 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,409 | 3,980 | Shares | Sole | 2026-08-04 | |
| No filing history on record for this holder in this stock. | ||||||